Mendelsohn Aaron
SEC Form 4 insider trading activity
Mendelsohn Aaron has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Oct 19, 2026.
On the most recent filing, Mendelsohn Aaron is listed as Director at Vivani Medical, Inc. Inside the rolling window, Mendelsohn Aaron reported 1 open-market purchase totaling $25K in VANI and no open-market sales.
Companies traded
Other insiders at VANI
Insider Buying
$25K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Mendelsohn Aaron made?
Mendelsohn Aaron has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Mendelsohn Aaron trade?
Mendelsohn Aaron has filed SEC Form 4 disclosures for 1 company, including VANI.
When was Mendelsohn Aaron's most recent SEC Form 4 filing?
Mendelsohn Aaron's most recent SEC Form 4 filing on Tracefour is dated Oct 19, 2026.
What is Mendelsohn Aaron's total buy and sell value in the current window?
Inside the rolling retention window, Mendelsohn Aaron bought $25K and sold $0 based on SEC Form 4 filings.
What was Mendelsohn Aaron's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 20,000 VANI shares on 2025-12-29, worth $25K, per SEC Form 4 filings.